D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EVH holding history
Evolent Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVH overviewAll 13F holders of EVHFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,107,561
- Value
- $27.7M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,107,561 | $27.7M | <0.1% | −326,471−6.0% | Reduced | Holders |
| Q1 2026 | 5,434,032 | $12.4M | <0.1% | +164,730+3.1% | Added | Holders |
| Q4 2025 | 5,269,302 | $21.1M | <0.1% | +2,531,506+92.5% | Added | Holders |
| Q3 2025 | 2,737,796 | $23.2M | <0.1% | +633,423+30.1% | Added | Holders |
| Q2 2025 | 2,104,373 | $23.7M | <0.1% | +225,373+12.0% | Added | Holders |
| Q1 2025 | 1,879,000 | $17.8M | <0.1% | +1,255,929+201.6% | Added | Holders |
| Q4 2024 | 623,071 | $7.01M | <0.1% | +623,071 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −7,888−100.0% | Sold out | Holders |
| Q1 2023 | 7,888 | $256.0K | <0.1% | −57,324−87.9% | Reduced | Holders |
| Q4 2022 | 65,212 | $1.83M | <0.1% | −341,732−84.0% | Reduced | Holders |
| Q3 2022 | 406,944 | $14.6M | <0.1% | −105,210−20.5% | Reduced | Holders |
| Q2 2022 | 512,154 | $15.7M | <0.1% | +165,854+47.9% | Added | Holders |
| Q1 2022 | 346,300 | $11.2M | <0.1% | +229,471+196.4% | Added | Holders |
| Q4 2021 | 116,829 | $3.23M | <0.1% | +107,571+1,161.9% | Added | Holders |
| Q3 2021 | 9,258 | $287.0K | <0.1% | −43,277−82.4% | Reduced | Holders |
| Q2 2021 | 52,535 | $1.11M | <0.1% | +3,733+7.6% | Added | Holders |
| Q1 2021 | 48,802 | $986.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.